NCT02549937 2024-07-10A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid TumorsHutchmedPhase 1/2 Completed130 enrolled 30 charts
NCT05093322 2024-06-07A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid TumorsHutchmedPhase 1/2 Completed13 enrolled 17 charts